Cargando…
Performance of a [(18)F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies
BACKGROUND AND OBJECTIVES: Recently, the US Food and Drug Administration approved the tau-binding radiotracer [(18)F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease (AD). Studies evaluating this vis...
Autores principales: | Coomans, Emma M., de Koning, Lotte A., Rikken, Roos M., Verfaillie, Sander C.J., Visser, Denise, den Braber, Anouk, Tomassen, Jori, van de Beek, Marleen, Collij, Lyduine E., Lemstra, Afina W., Windhorst, Albert D., Barkhof, Frederik, Golla, Sandeep S.V., Visser, Pieter Jelle, Scheltens, Philip, van der Flier, Wiesje M., Ossenkoppele, Rik, van Berckel, Bart N.M., van de Giessen, Elsmarieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663007/ https://www.ncbi.nlm.nih.gov/pubmed/37748892 http://dx.doi.org/10.1212/WNL.0000000000207794 |
Ejemplares similares
-
Hippocampal [(18)F]flortaucipir BP(ND) corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships
por: Wolters, Emma E, et al.
Publicado: (2019) -
Regional [(18)F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
por: Wolters, Emma E., et al.
Publicado: (2020) -
Associations between quantitative [(18)F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
por: Timmers, Tessa, et al.
Publicado: (2019) -
Test–retest repeatability of [(18)F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals
por: Timmers, Tessa, et al.
Publicado: (2019) -
Effect of Shortening the Scan Duration on Quantitative Accuracy of [(18)F]Flortaucipir Studies
por: Tuncel, Hayel, et al.
Publicado: (2021)